Skip to content
Clinical Trials – home

PALMIDROL (Palmitoylethanolamide): A Promising Supplement for Various Health Conditions

1 / 1
trials open to patients / all trials
1+
Countries

In short

Palmidrol, also known as palmitoylethanolamide (PEA), is a naturally occurring fatty acid amide that has been the subject of numerous clinical trials investigating its potential therapeutic benefits. This article provides an overview of recent studies exploring the use of PEA in various medical conditions, including chronic pain, neuropathy, depression, and inflammatory disorders. We'll examine the current research, potential applications, and what these trials reveal about PEA's efficacy and safety profile.

At a glance

Main Compound
Palmidrol (Palmitoylethanolamide, PEA)
Conditions Studied
Chemotherapy-induced neuropathy, Major depression, Chronic pain, Tourette syndrome, Opioid use disorder, Endometriosis-related pain, ALS
Common Dosages
600-1200 mg/day, often divided into two doses
Administration
Oral capsules or tablets, sometimes micronized or ultra-micronized
Mechanism of Action
Activates PPAR-α, modulates inflammation and pain pathways
Safety Profile
Generally well-tolerated with minimal reported side effects
Trial Designs
Randomized controlled trials, N-of-1 trials, open-label studies
Outcome Measures
Pain scales, quality of life assessments, functional status, biomarkers
Potential Benefits
Pain reduction, improved function, decreased inflammation, potential neuroprotection
Research Status
Ongoing clinical trials in various phases, from pilot studies to larger efficacy trials

What is PALMIDROL?

PALMIDROL, also known as Palmitoylethanolamide (PEA), is a naturally occurring fatty acid amide that has gained attention for its potential therapeutic properties. It is an endogenous compound, meaning it is produced naturally in the body, and is part of a class of molecules called N-acylethanolamines (NAEs). PEA is found in various foods such as peanuts, egg yolks, and soybeans.

PALMIDROL is known by several other names, including:

  • N-Palmitoyl Ethanolamide
  • N-Palmitoylethanolamide
  • Palmitoyl Ethanolamide
  • Palmitoylethanolamide
  • PEA

How PALMIDROL Works

PALMIDROL works in several ways to help reduce pain and inflammation in the body:

  1. Anti-inflammatory effects: PEA modulates immune responses, inhibits mast cell activation (cells involved in allergic and inflammatory responses), and reduces the release of pro-inflammatory substances called cytokines.
  2. Pain reduction: PEA interacts with various receptors and channels in the body, including PPAR-α (peroxisome proliferator-activated receptor alpha), TRPV1 channels, and GPR55 receptors. These interactions help to reduce pain signals.
  3. Neuroprotection: Some studies suggest that PEA may have protective effects on nerve cells, which could be beneficial in conditions affecting the nervous system.

Conditions Treated with PALMIDROL

Research suggests that PALMIDROL may be beneficial for various health conditions, including:

  • Chronic pain: Studies have shown potential benefits in treating different types of chronic pain, including neuropathic pain (pain caused by nerve damage) and inflammatory pain.
  • Chemotherapy-induced peripheral neuropathy: This is a nerve problem causing pain, numbness, tingling, or muscle weakness in different parts of the body due to chemotherapy treatment.
  • Depression: Some research is exploring the use of PEA for major depression, including both unipolar and bipolar depression.
  • Tourette Syndrome: PEA is being studied in combination with other compounds for the treatment of Tourette Syndrome, a disorder characterized by repetitive, involuntary movements and vocalizations.
  • Endometriosis and chronic pelvic pain: PEA has shown promise in reducing pain associated with endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus.
  • Amyotrophic Lateral Sclerosis (ALS): Research is ongoing to determine if PEA can help with symptoms of ALS, a progressive nervous system disease that affects nerve cells in the brain and spinal cord.
  • Eczema: Topical formulations of PEA are being studied for their potential to reduce symptoms of eczema, a condition causing dry, itchy, and inflamed skin.

Dosage and Administration

The dosage and administration of PALMIDROL can vary depending on the condition being treated and the specific formulation used. Some common dosages observed in clinical trials include:

  • 600 mg twice daily (1200 mg total per day) for various pain conditions
  • 300 mg to 1200 mg daily for depression
  • Topical application for skin conditions like eczema

PALMIDROL is available in various forms, including oral capsules, tablets, and topical creams. Always follow the dosage instructions provided by your healthcare provider or as indicated on the product label.

Safety and Side Effects

PALMIDROL is generally considered safe and well-tolerated. Clinical trials have reported minimal side effects, making it a potentially attractive option for long-term use in chronic pain management. However, as with any supplement or medication, it's important to consult with a healthcare professional before starting use, especially if you have any existing health conditions or are taking other medications.

Ongoing Research

Several clinical trials are currently underway to further investigate the potential benefits of PALMIDROL for various conditions. These studies aim to provide more concrete evidence on its efficacy and optimal use. Some areas of ongoing research include:

  • Combination therapy with other compounds for enhanced effects
  • Use in opioid use disorder to reduce cravings and manage pain
  • Potential neuroprotective effects in conditions like ALS

As research continues, we may gain a better understanding of how PALMIDROL can be used effectively in various health conditions. If you're considering using PALMIDROL, it's important to discuss it with your healthcare provider to determine if it's appropriate for your specific situation.

Questions people often ask

Conditions where Palmidrol is being studied

Each condition opens its own overview and trial list

Trials with Palmidrol

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).